SEC Filing Summary: Ra Medical Systems, Inc. (RMED)
Business Context and Reporting Period
This Form 8-K Current Report was filed by Ra Medical Systems, Inc. (not Catheter Precision, Inc.) on December 14, 2022. The report addresses a specific corporate governance event regarding the company's listing status on the NYSE American.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance status rather than financial performance.
Material Changes
- Listing Compliance: The Company received confirmation from the NYSE American on December 8, 2022, that it has regained compliance with continued listing standards.
- Resolution of Deficiency: The specific deficiency resolved was related to the Company's low selling price, as outlined in Section 1003(f)(v) of the NYSE American Company Guide.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or a discussion of new risks. The primary risk addressed was the potential delisting due to low share price, which has been resolved as of the report date.
Investor Verification Checklist
- Verify the current share price of RMED to ensure continued compliance with NYSE American listing standards.
- Review the attached Press Release (Exhibit 99.1) for any additional details on the compliance process.
- Confirm the company's ticker symbol is RMED and it trades on the NYSE American.
- Note that this filing does not contain updated financial statements; refer to the most recent 10-Q or 10-K for financial data.